Edition:
United States

Biotechnology & Medical Research

Biocon Says European Medicines Agency's CMPH Recommends Approval Of Fulphila

Sept 21 (Reuters) - Biocon Ltd ::BIOCON SAYS EUROPEAN MEDICINES AGENCY'S COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE HAS ISSUED POSITIVE OPINION RECOMMENDING APPROVAL OF FULPHILA.SAYS CHMP POSITIVE OPINION WILL NOW BE CONSIDERED BY THE EUROPEAN COMMISSION.SAYS DECISION ON APPROVAL IS EXPECTED...

9:33am EDT

Integragen H1 Operating Loss Narrows To 0.5 Million Euros

Sept 20 (Reuters) - INTEGRAGEN SA ::H1 NET LOSS EUR 0.5 MILLION VERSUS LOSS OF EUR 0.5 MILLION YEAR AGO.H1 SALES EUR 3.6 MILLION VERSUS EUR 3.1 MILLION YEAR AGO.H1 OPERATING LOSS EUR 0.5 MILLION VERSUS LOSS OF EUR 1.2 MILLION YEAR AGO.IN JUNE 2018, NET CASH POSITION AMOUNTED TO EUR 3.3 MILLION...

Thursday, 20 Sep 2018 12:30pm EDT

Elbit Imaging Announces Gamida Cell Appointed New Chairman

Sept 20 (Reuters) - Elbit Imaging Ltd ::ELBIT IMAGING ANNOUNCES THAT GAMIDA CELL HAS APPOINTED A NEW CHAIRMAN OF THE BOARD.ELBIT IMAGING LTD - ROBERT BLUM CURRENTLY ALSO SERVES AS PRESIDENT AND CEO OF CYTOKINETICS.

Thursday, 20 Sep 2018 09:49am EDT

Corbus Pharmaceuticals Says Co Obligated To Pay Jenrin Potential Milestone Payments Of Up To $18.4 Mln For Each Compound Elects To Develop

Sept 20 (Reuters) - Corbus Pharmaceuticals Holdings Inc ::CORBUS PHARMACEUTICALS- CO OBLIGATED TO PAY JENRIN POTENTIAL MILESTONE PAYMENTS OF UP TO $18.4 MILLION FOR EACH COMPOUND ELECTS TO DEVELOP.CORBUS PHARMACEUTICALS SAYS CO OBLIGATED TO PAY JENRIN ROYALTIES IN MID, SINGLE DIGITS BASED ON NET...

Thursday, 20 Sep 2018 08:53am EDT

Mergers & Acquisitions

Expansion & New Markets

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.